BioNTech SE
BNTX
$93.66
$0.320.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 135.53M | 1.06B | 1.78B | 295.99M | 192.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 135.53M | 1.06B | 1.78B | 295.99M | 192.37M |
| Cost of Revenue | 81.94M | 352.49M | 173.38M | 86.71M | 88.19M |
| Gross Profit | 53.59M | 703.81M | 1.60B | 209.28M | 104.18M |
| SG&A Expenses | 173.06M | 253.66M | 173.61M | 155.94M | 126.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.84M | 214.08M | 807.04M | -28.83M | -12.52M |
| Total Operating Expenses | 917.04M | 1.41B | 1.81B | 791.61M | 755.69M |
| Operating Income | -781.51M | -352.26M | -38.58M | -495.62M | -563.32M |
| Income Before Tax | -651.94M | -264.72M | 28.88M | -457.04M | -468.71M |
| Income Tax Expenses | -41.54M | 90.33M | 62.43M | -18.27M | -31.15M |
| Earnings from Continuing Operations | -610.40M | -355.05M | -33.55M | -438.76M | -437.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -610.40M | -355.05M | -33.55M | -438.76M | -437.57M |
| EBIT | -781.51M | -352.26M | -38.58M | -495.62M | -563.32M |
| EBITDA | -642.30M | -310.76M | 106.62M | -437.74M | -518.28M |
| EPS Basic | -2.41 | -1.46 | -0.14 | -1.82 | -1.82 |
| Normalized Basic EPS | -1.61 | -0.62 | 0.12 | -1.11 | -1.26 |
| EPS Diluted | -2.41 | -1.46 | -0.14 | -1.82 | -1.82 |
| Normalized Diluted EPS | -1.61 | -0.62 | 0.12 | -1.11 | -1.26 |
| Average Basic Shares Outstanding | 253.29M | 244.00M | 239.17M | 241.63M | 240.35M |
| Average Diluted Shares Outstanding | 253.29M | 244.00M | 239.17M | 241.63M | 240.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |